[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![chandrakar_c Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::748690704000483328.png) Dev Investor @ Dev chandrakar [@chandrakar_c](/creator/twitter/chandrakar_c) on x XX followers
Created: 2025-07-25 10:37:45 UTC

Business Mix: Q1 FY26 revenue split is XX% Research Services (CRO) and XX% Manufacturing (CDMO). This mix is dynamic and can fluctuate.

Focus on Emerging Biologics: Investing in fast-growing large molecule modalities beyond monoclonal antibodies (e.g., ADCs, peptides, oligos, protax). Inaugurated a new peptide facility.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948694153220567109/c:line.svg)

**Related Topics**
[cro](/topic/cro)
[investment](/topic/investment)

[Post Link](https://x.com/chandrakar_c/status/1948694153220567109)